How Quitting Smoking Can Quickly Lower Risk Of A-Fib
Smokers who make the decision to quit will experience immediate health benefits, including a rapid reduction in their risk of atrial fibrillation (A-Fib), according to new research published in JACC: Clinical Electrophysiology. The study, conducted by Dr. Gregory Marcus, a cardiologist at the University of California, San Francisco, offers compelling evidence for smokers to quit, showing that it’s never too late to avoid the damaging effects of smoking on heart health.
Dr. Marcus, the senior author of the study, emphasized that A-Fib can be prevented even in individuals who have smoked for years. "The findings provide a compelling new reason to show current smokers that it’s not too late to quit, and that having smoked in the past doesn’t mean you’re ‘destined’ to develop A-Fib," Marcus explained. "Even for the current and longtime smoker, A-Fib can still be avoided."
"There’s strong evidence that smoking increases the risk of A-Fib," Marcus said. "But the benefits of quitting smoking have been less certain." With this in mind, his team sought to determine whether quitting could significantly lower a person’s risk of developing A-Fib, or if the risk would remain the same.
The research team analyzed data from over 146,700 current and former smokers, tracking their smoking habits and health over a 12-year period using data from the UK Biobank database. The results were promising: former smokers had a 13% lower risk of developing A-Fib compared to current smokers, while those who quit during the study saw an 18% reduction in their risk.
"This is likely a testament to the potency of reducing atrial fibrillation risk pretty shortly after quitting," Marcus said in a statement from the American College of Cardiology.
The findings highlight the importance of quitting smoking, not only for general health but specifically for reducing the risk of serious heart conditions like A-Fib.
Quitting smoking is one of the most effective ways to lower the risk of A-Fib and improve overall heart health. While it can be challenging, the benefits of quitting are clear and immediate. Here are some tips to help you quit smoking successfully:
1. Choose a specific date to quit smoking and stick to it. Prepare yourself mentally and physically for this change.
2. Reach out to family, friends, or a support group to help keep you accountable. Sharing your goals with others can provide encouragement.
3. Options like nicotine patches, gum, or lozenges can help ease withdrawal symptoms and reduce cravings.
4. Identify situations that make you want to smoke, such as stress or social gatherings, and find healthy ways to cope with them.
5. Regular exercise can help distract you from cravings and improve your mood during the quitting process.
6. Drinking water can help flush nicotine out of your system faster, reducing cravings.
7. Activities like yoga, meditation, or deep breathing exercises can help manage stress, a common trigger for smoking.
Quitting smoking offers immediate and significant benefits, particularly in reducing the risk of atrial fibrillation. The latest research provides smokers with more motivation to quit, showing that it's never too late to take control of their heart health.
Credit: iStock
Amid an ongoing Salmonella outbreak that has infected hundreds of people, vulnerable groups in the UK are being advised to avoid undercooked or runny eggs.
The Food Standards Agency (FSA) issued the precautionary advice after the UK Health Security Agency (UKHSA) declared a national outbreak. The outbreak has infected 207 people across the UK, with one death and 34 hospitalisations.
Officials suspect imported eggs or food products containing imported eggs may be behind the outbreak.
However, the FSA said well-cooked eggs served in restaurants, cafes and takeaways are safe to eat.
Who Is at Risk?
The FSA advised vulnerable groups, including:
Ian Young, chief scientific adviser at the FSA, said vulnerable people eating out should ensure that eggs and egg products are thoroughly cooked.
Which Foods Should Be Avoided?
The FSA advised vulnerable people to avoid runny eggs and freshly made foods that may contain uncooked eggs, including:
Are Supermarket Eggs Safe?
Young reiterated that people can continue to buy British eggs from supermarkets. Chickens bred in the UK are vaccinated against common strains of Salmonella.
“There is no link to those eggs to this current outbreak,” he said.
He described the outbreak as “unusually large and rapidly increasing” and urged people to take precautions.
The UKHSA has launched an investigation to identify the source of the outbreak. Initial findings suggest it may be linked to eggs imported from outside the UK, although the source has not yet been definitively established.
Dr Kathleen O'Reilly, associate professor at the London School of Hygiene & Tropical Medicine, said the investigation involves identifying additional cases and examining possible common sources of infection.
Where Have Cases Been Reported?
Cases have been reported across the UK:
In England, London has reported the highest number of cases, with 47, followed by Yorkshire and the Humber with 38.
What Is Salmonella?
Salmonella is a bacterial infection that commonly causes diarrhoea and gastrointestinal illness.
Common symptoms include:
How Does Salmonella Spread?
The UKHSA stated that Salmonella Enteritidis is the most common Salmonella serovar in England and a leading cause of salmonellosis.
Like other non-typhoidal Salmonella infections, it can spread through contaminated food, including:
The bacteria can also spread through contact with contaminated environments or from person to person.
How to Reduce the Risk of Salmonella
Dr O'Reilly advised people to fully cook eggs before eating them and maintain good food hygiene.
Key precautions include:
People who develop diarrhoea or stomach cramps should rest and drink plenty of fluids. Young children, older adults and other vulnerable people who become ill should seek medical advice.
Credit: iStock
Moderna and Merck’s personalized mRNA cancer vaccine has shown statistically significant and clinically meaningful improvements. The late-stage trial showed recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) when combined with Keytruda in patients with melanoma, an aggressive form of skin cancer.
The vaccine, intismeran autogene (mRNA-4157/V940), is custom-made for each patient based on the unique genetic characteristics of their tumor. It is designed to work alongside Keytruda (pembrolizumab), an immunotherapy that helps the immune system attack cancer cells.
According to experts, the development moves personalized cancer therapy closer to a practical clinical reality.
“A tumor-specific mRNA vaccine offers a way of making the immune response more targeted by using the individual tumor’s molecular characteristics to identify the abnormal signals that the immune system should recognize,” Prof. Jyoti Bajpai, Director – Medical Precision Immuno-Oncology, Apollo Hospitals, Mumbai, told HealthandMe.
In the Phase 3 INTerpath-001 trial, the combination met its primary endpoint of recurrence-free survival (RFS) and a key secondary endpoint of distant metastasis-free survival (DMFS).
Compared with Keytruda alone, the combination of intismeran autogene and Keytruda showed statistically significant and clinically meaningful improvements in both RFS and DMFS.
The findings were reported in patients with stage IIB, IIC, III, or IV cutaneous melanoma who had undergone complete surgical removal of their cancer and had not previously received systemic therapy.
After tumor sequencing, up to ~34 patient-specific neoantigens are encoded into a single mRNA construct delivered in lipid nanoparticles.
Host cells translate the neoantigens, which are then presented on MHC, driving de novo and expanded neoantigen-specific CD8+ and CD4+ T-cell responses.
When combined with PD-1 blockade, the vaccine supplies the antigenic “signal” while the checkpoint inhibitor supplies the “permission” to attack.
“The result is a more focused, polyclonal, and potentially longer-lived anti-tumor immune response—exactly what is needed to clear residual microscopic disease after resection,” Dr. Shyam Aggarwal, Chairman, Medical Oncology, Sir Ganga Ram Hospital, told HealthandMe.
Early translational data from KEYNOTE-942 already showed durable neoantigen-specific T-cell responses, supporting the idea that the vaccine can generate immune memory that outlasts the treatment period.
“Immunotherapy releases the body’s natural brakes to attack cancer, whereas the custom vaccine acts like a precision GPS—training the immune system to recognize the unique genetic signature of that patient's specific tumour. Immunotherapy mobilizes the immune response, but the vaccine tells it exactly where to go,” Prof. Jyoti said.
“The practical implication is a shift in the adjuvant paradigm: rather than relying solely on broad immune checkpoint inhibition or chemotherapy, we can now envision adding a tumor-specific ‘instruction set’ that educates the patient’s own T-cell repertoire against the unique mutational fingerprint of their cancer,” the noted oncologist said.
He added that the manufacturing turnaround, currently ~6 weeks from biopsy to first dose, remains a logistical and cost challenge. However, the COVID-era mRNA infrastructure has shown that rapid, decentralized production of custom constructs is feasible.
India’s cancer burden has continued to rise steadily over the past five years, with the estimated number of new cancer cases increasing from 14.26 lakh in 2021 to 15.70 lakh in 2025, while annual cancer-related deaths also climbed from 7.89 lakh to an estimated 8.69 lakh during the same period, according to data placed before Parliament recently.
For India, this technology has intriguing potential, Dr Jyoti said.
While typical skin melanoma is less common here, India sees higher rates of acral and mucosal subtypes, which tend to be aggressive and diagnosed late.
“A tailored neoantigen approach could be very useful for these complex cases. However, manufacturing costs, long turnaround times for genomic sequencing, and cold-chain logistics mean translating this into routine clinical care in India may take time,” she added.
Credit: CDC
Almost all states in the US are reporting a growing summer wave of COVID-19 cases, according to a report by the Centers for Disease Control and Prevention (CDC).
While the numbers aren’t especially high and there aren’t many hospitalizations or deaths, the test positivity rate for the week ending August 8 rose above 3% for the first time since March, with numbers climbing in every state. Emergency department visits related to COVID-19 are also “very low.”
Wastewater Data Offers Closer Look At COVID Activity
According to the CDC, wastewater data can be a key tool for tracking where the virus may be circulating. Testing sewage can detect the presence of COVID-19 in a community and “can pick up signs of infection even from people who feel perfectly healthy,” the CDC said.
COVID-19 Activity By State
“It is going up. We don’t know how to describe these numbers that we’re seeing in terms of what the denominator is anymore,” Dr. Scott Harris, state health officer for the Alabama Department of Public Health, told the media.
“Now we just know when we get a positive test, and we don’t even have clinical data sometimes to put that in context.”
‘August Is Solidly Covid Season’
“August is solidly Covid season,” Dr. Caitlin Rivers, an expert in outbreak science and senior scholar at the Johns Hopkins Center for Health and Security, told CNN.
“Right now, the South and the West are sort of the leading edge of this Covid season. In the past, it almost always starts in Florida, Texas and Georgia, which is exactly what we’re seeing this year.”
Who Is At Higher Risk?
COVID-19 can still be serious and even deadly, especially for people who remain vulnerable to severe disease. These include:
How To Prevent COVID-19?
To reduce the risk of infection, people should:
Anyone experiencing symptoms such as fever, cough or breathlessness should get tested and seek timely medical advice.
If you didn’t get a COVID-19 vaccine last year, you may want to talk to your healthcare provider or pharmacist about getting one, including the vaccine formulated for last season, Dr. James McDonald, commissioner of health for the New York State Department of Health, told CNN.
© 2024 Bennett, Coleman & Company Limited